SNPS vs TARS · P/E 63, rev $7.16B vs rev $336.0M
Synopsys Inc (SNPS) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. TARS currently screens at market cap $2.66B.
Not investment advice. Open the SNPS and TARS stock pages for the full models.
Not investment advice.